Cell Therapeutics (CTIC) Announces $21M Preferred Registered Offering
Tweet Send to a Friend
Cell Therapeutics, Inc. (Nasdaq: CTIC) today announced that it has entered into an agreement to sell $21.0 million of shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


